PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
Felcana is a patented Eco-system of connected devices: Helix, Home Hub, Micro-Location Beacons and the Felcana application which work together to monitor the pet's (cat or dogs) well-being. This Digital Pet Health Platform tracks pet's behaviour and provides the vet, rich data leading to faster diagnosis and faster treatment. Felcana has been developed by a world-class team of vets and engineers and, it has been designed and tested by using the latest materials, designs, and techniques. Felcana has won the Design Spark Award in 2017. It is making unique partnerships with leading pet industries and the UK's largest pet health plan provider, the world's top-ranked vet school and The Royal Veterinary College. The new investment will enable it to grow consumer reach and accelerate its sales.
days to go:
Expired
investment:
£343,926
Ruby Violet (RV) creates ice cream flavours, vegan sorbets and iced delights. It asserts that it has grown from a market stall in 2011, to two parlours and an accompanying vintage van, tricycle and trolley, almost doubling its revenue from 2016 to 2019. RV aims to become a contender in the ice cream industry that is worth £1.4 billion in the UK and £44 billion worldwide. It asserts that 90% of the packaging used by the company is either recyclable or compostable. It has featured in press entities like The Times, The Guardian, Vogue and the BBC, to name a few. RV has also collaborated with noted gin company, Gin Mare, creating gin ice cream and sorbet specific to their infused botanicals. RV's clients include Costa Coffee, Nike, McVitie's, and Moet & Chandon. It will use 75% of the investment for capital expenditure, 15% for marketing activities, and 10% for hiring key personnel.
days to go:
Expired
investment:
£357,173
Electric Assisted Vehicles Limited or EAV is a new generation vehicle design and manufacturing company providing a world-class solution. In August, the company has been revealed at the UK EV summit in Oxford. DPD is the technical partner of EAV and it has issued Letter of Intent for 50 more EAVans. With the proceeds, the company will expand into the international market, develop the product and will set its business lease plans.
days to go:
Expired
investment:
£215,130
Doisy & Dam (D&D) is a confectionery challenger brand that produces a range of dark chocolate products. It claims that its products are sold across the UK and stocked by Amazon, Sainsbury's, Holland & Barrett, Ocado, Boots, and other global markets. D&D's products are created using ethically sourced cocoa, natural ingredients and contain no traces of palm oil. The company aspires to become a contender in the UK confectionery market that was worth £3.9 billion in April 2021. It further points out that people are aware of the health and the sustainability credentials of the products they buy. It intends to target this sentiment and become an established brand. The company states it has grown its sales to over £1 million and aspires to become the best dark chocolate confectioner in the UK. D&D state they will use the investment for marketing, expanding its product range, and growing its export business.
days to go:
Expired
investment:
£515,735
Get Set Pet (GSP) is a pet supply challenger brand on a mission to build a community of like-minded dog and cat owners that take pride in their relationships with their pets. The company aims to arm pet parents with the information they need to make better nutrition decisions regardless of whether or not they shop with GSP. GSP has acquired over 15,000 customers, generated over 20,000 orders, and delivered £800,000 in total sales. The company has 4.97 out of 5 'Excellent' ratings from over 1,100 verified customer reviews. GSP will use 25% of the investment towards Research and Development (R&D) of its products, 25% on salaries, technology investments and working capital, and 50% on marketing and promotional activities.
days to go:
Expired
investment:
£386,375
Hippo aims to be the dedicated transportation service for non-emergency and impaired medical victims. With private care homes as customers and an NHS deal secured, they intend to allow quicker hospital bed rotation, free ambulances to attend more emergencies and decreased A&E waiting times. It is currently operating in South East Essex, having an association with South Essex Care & Health Association, and have an NHS deal in place as well. For the future, Hippo aims to develop a specialised management and booking solution that will combine its video camera system, so that patients can be monitored during the journey by the NHS and family members.
days to go:
Expired
investment:
£175,390
